You are here

Home

Research

Colds and Flu may cause long-term infections similar toCovid--UK study

Fri, 2023-10-06 11:26 — mike kraft
UK researchers find evidence of ‘long cold’ syndrome Research published Friday shows various acute respiratory infections, such as pneumonia, influenza and the common cold, may present with long-term symptoms, similar to COVID-19. “Long cold” symptom… nrobertson The Hill

...

“Long cold” symptoms could linger for up to four weeks in some cases, much like “long COVID,” the UK-based researchers said.

Country / Region Tags: 
Europe
Global
UK - London
United Kingdom
General Topic Tags: 
Seasonal Flu
Symptoms
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Solutions

European study outlines good practices and lessons learned from COVID school closings

Fri, 2023-10-06 11:19 — mike kraft
ECDC, Sweden detail good practices, lessons learned from COVID school-closure policies The report spells out the complex issues that drove its policies, along with some data gaps officials encountered. CIDRAP

 

 

Country / Region Tags: 
Europe
Sweden
General Topic Tags: 
COVID-19
Disease Prevention
Policy
Public Health
Research
Social behavior
Problem, Solution, SitRep, or ?: 
Analysis

Analysis: Why people who qualify should get the RSV vaccine

Thu, 2023-10-05 19:02 — mike kraft
Why it’s a big deal that there is an RSV vaccine for older adults | CNN Respiratory syncytial virus, or RSV, kills 10,000 to 13,000 older adults annually. Here’s why Dr. Leana Wen recommends people get the new RSV vaccines available for older people, pregnant people and infants. Katia Hetter CNN
Country / Region Tags: 
Global
United States
General Topic Tags: 
Disease
Disease Prevention
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Analysis: The new COVID shot is a game-changer, and why

Wed, 2023-10-04 17:34 — mike kraft

 

Why the new COVID shot is a game-changer (and why the term ‘booster’ is obsolete) The latest vaccine formula is available in local pharmacies now. Experts say it will be like the annual flu shot: one and done. Here’s why. Science

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Health
Mutations
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Novavax : US FDA authorizes Novavax's updated COVID shot; CDC additional approval not neeed.

Wed, 2023-10-04 17:22 — mike kraft
US FDA authorizes Novavax's updated COVID shot, shares rise The U.S. Food and Drug Administration said on Tuesday it authorized an updated version of Novavax's COVID-19 vaccine for emergency use in individuals aged 12 years and older, and the company's shares closed 8% higher. Sriparna Roy,Michael Erman Reuters

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Government
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Moderna combination Covid, flu vaccine moves to final stage trial after positive data

Wed, 2023-10-04 09:26 — mike kraft

Moderna combination Covid, flu vaccine shows positive data (cnbc.com)

 

  • Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial after showing positive results in an earlier study.
  • The biotech company is hoping its shot, mRNA-1083, can win approval from regulators in 2025. 

...

 

 

 

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Mutations
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Problem
Situation Report

Best results from home Covid-19 tests come several days after symptoms --study

Tue, 2023-10-03 10:56 — mike kraft

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Disease
Health
Medical Testing
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis

Paxlovid cuts hospitalization, death only in COVID patients with weak immune systems -- Canadian study

Tue, 2023-10-03 10:44 — mike kraft

 

Study: Paxlovid cuts hospitalization, death only in at-risk COVID patients with weak immune systems seb_ra / iStock CIDRAP

...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.

...

 

 

Country / Region Tags: 
Canada
General Topic Tags: 
COVID-19
Symptoms
Treatments
Data
Demographics
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

WHO authorizes a second malaria vaccine. Experts warn it’s not enough to stop the disease spreading

Tue, 2023-10-03 10:24 — mike kraft
UN authorizes a second malaria vaccine. Experts warn it's not enough to stop the disease spreading The World Health Organization has authorized a second malaria vaccine in a decision that could offer countries a cheaper and a more readily available option than the world’s first shot against the parasitic disease. AP News

...

Country / Region Tags: 
Africa
Asia
India
UK - London
United Kingdom
General Topic Tags: 
Disease Prevention
Health
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Florida COVID case count decreases again, but deaths pass 91,000 mark

Mon, 2023-10-02 12:22 — mike kraft
COVID case count in Florida decreases again, but deaths pass 91,000 mark The latest report also revealed that 91,178 residents had died with COVID-19 as of Thursday. That was up from a reported 90,740 deaths two weeks earlier. HEALTHNEWSFL

 

Country / Region Tags: 
United States
US - South
General Topic Tags: 
COVID-19
Contagion
Data
Disease
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Research
howdy folks